International Stem Cell Corp. (ISCO.OB) Inks Distribution Agreement with Sristi Biosciences
International Stem Cell Corp. and its subsidiary Lifeline Cell Technology ® have entered into an agreement with Sristi Biosciences for the distribution of the Lifeline brand of human cell culture products in India. Lifeline develops, manufactures and distributes primary human cells and media and growth factors for optimized culturing of cells, including stem cells. The company notes international requests for its products, including India, one of the fastest growing markets for such products. Lifeline CEO and senior vice president of Operations at ISCO, Jeffrey Janus, said Sristi Biosciences is highly experienced in advanced cell therapy, and that the company has…